Rapport Therapeutics, Inc. Common Stock (RAPP)

10.27

(0.88%)

Revenue Summary of Rapport Therapeutics, Inc. Common Stock

  • Rapport Therapeutics, Inc. Common Stock's latest annual revenue in 2023 was - USD , down 0.0% from previous year.
  • Rapport Therapeutics, Inc. Common Stock's latest quarterly revenue in 2024 Q2 was - USD , down 0.0% from previous quarter.
  • Rapport Therapeutics, Inc. Common Stock reported a annual revenue of - USD in annual revenue 2022, down 0.0% from previous year.
  • Rapport Therapeutics, Inc. Common Stock reported a quarterly revenue of - USD for 2024 Q1, down 0.0% from previous quarter.
  • Rapport Therapeutics, Inc. Common Stock reported a quarterly revenue of - USD for 2023 FY, down 0.0% from previous quarter.

Annual Revenue Chart of Rapport Therapeutics, Inc. Common Stock (2023 - 2022)

Historical Annual Revenue of Rapport Therapeutics, Inc. Common Stock (2023 - 2022)

Year Revenue Revenue Growth
2023 - USD 0.0%
2022 - USD 0.0%

Peer Revenue Comparison of Rapport Therapeutics, Inc. Common Stock

Name Revenue Revenue Difference